Danske Upgrades AstraZeneca (AZN) to Buy
Tweet Send to a Friend
Danske upgraded AstraZeneca (NYSE: AZN) from Sell to Buy.
This article: 48 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 48 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE